GO
Loading...

Medicine

More

  • Pfizer's Unlucky 13-Year Milestone Wednesday, 25 Feb 2009 | 4:02 PM ET

    September 1996. I was in the middle of my nearly 10-year stint at WXYZ-TV in Detroit. And shares of Dow component Pfizer closed at $12.90. February 2009. This year will mark my ninth anniversary (man, time flies) at CNBC. And today PFE hit a new intra-day low of $12.90.

  • New Rx For Big Pharma Wednesday, 25 Feb 2009 | 8:24 AM ET

    Big pharma has to change the way it sells drugs. That's the conclusion of a new PricewaterhouseCoopers report about what the industry will look like in 2020, which calls the big pharma sales model "increasingly ineffective."

  • Pfizer's February Failures Tuesday, 24 Feb 2009 | 11:25 AM ET
    Pfizer

    This morning the world's biggest pharmaceutical firm announced that it's scrapping two more drugs that were in late-stage studies.

  • Generic Drugmakers Are Puttin' On The Ritz Monday, 23 Feb 2009 | 2:26 PM ET
    Ritz Carlton Naples

    At the risk of offending our gracious hosts here at the Generic Pharmaceutical Association's Silver Anniversary Meeting, I wanted to talk about the seemingly incongruous venue for the event.

  • The McDonald's Drug Pipeline & Your Emails Friday, 20 Feb 2009 | 10:00 AM ET

    Is there a pipeline from the C-suite of McDonald's to the ivory towers of biopharma? At least one "Pharma's Market" reader from overseas thinks so.

  • Amgen's Epogen & Pedal Pushers Thursday, 19 Feb 2009 | 8:26 AM ET
    Lance Armstrong

    The "Amgen Tour of California" is getting a lot more publicity than usual because superstar cyclists Lance Armstrong and Floyd Landis are trying to make comebacks in the race.

  • Eli Lilly Super-Sizes Its Board Wednesday, 18 Feb 2009 | 1:39 PM ET

    Yes, McDonald's has done away with "Super-Size" menu items, but I can still use the American lexicon for, hopefully, an attention-grabbing blog headline.

  • BEAT Beats The Street Wednesday, 18 Feb 2009 | 11:08 AM ET

    CardioNet caught my eye and attention when I got a research note from Rick Wise at Leerink Swann about BEAT beating the Street.

  • Stem Cells Sell Tuesday, 17 Feb 2009 | 1:45 PM ET

    Attendance at the 4th Annual Stem Cell Summit is up, by about 50 percent, no less, over last year. All day long privately-held and publicly-traded companies are presenting to around 250 investors.

  • Pfizer, Costco & Glaxo's Ofatumumab Friday, 13 Feb 2009 | 11:37 AM ET

    Friday the 13th. My lucky day for reaching into the Pharma's Market mailbag. Time for your Emails.

  • Pfizer's Ups And Downs Thursday, 12 Feb 2009 | 10:44 AM ET

    I thought the dust had pretty much settled on the Pfizer-Wyeth story. Then this morning two analysts coincidentally put out research notes on it.

  • Roche-Genentech: As The Deal Turns Tuesday, 10 Feb 2009 | 9:54 AM ET

    What's $23 between friends, er, sparring business partners? The question brings back memories of my grandfather who was of the generation that would hold a grudge for years against a distant relative who still owed him a small amount of money.

  • Hey, Genentech: Now It's Your Turn Friday, 6 Feb 2009 | 9:53 AM ET
    Arthur Levinson

    I've been trying for years to get an interview with Genentech CEO Art Levinson. As far as I know, he's never done a TV chat. Every time I've asked the answer has come back no. I've gotten pretty good access to other execs, but never the top dog.

  • Roche Still Gunning For Genentech Wednesday, 4 Feb 2009 | 10:51 AM ET

    Shares of Swiss drugmaker Roche are trading significantly lower overseas and in over-the-counter activity here in the States after the company reported earnings.

  • Progress For Eli Lilly & The FDA Tuesday, 3 Feb 2009 | 5:24 PM ET
    FDA

    Right around the closing bell today an FDA advisory committee voted unanimously in favor of recommending approval of Eli Lilly's bloodthinner called Effient.

  • Merck Lets Its Gardasil Down Tuesday, 3 Feb 2009 | 9:55 AM ET
    Gardasil

    Before Gardasil came to market two to three years ago, some analysts were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things.

  • Amylin In North Dakota? You Betcha Monday, 2 Feb 2009 | 1:37 PM ET
    Amylin

    Diabetes drugmaker Amylin Pharmaceuticals is headquartered in San Diego. Like a lot of companies, though, it's incorporated in Delaware. But, if a couple of major shareholders get their way, AMLN could reincorporate in an unlikely state.

  • So, what do you do at the end of a week where your company's stock was the worst performer in the Dow and you've got some bad news that could make the shares go down even more? You employ one of the oldest PR tricks in the book.

  • Roche Rocks Genentech Friday, 30 Jan 2009 | 5:06 PM ET

    Genentech shares dropped three percent today or $2.85 to $81.24 after Roche showed some chutzpah and lowered its bid for DNA. 

  • Pfizer's Time To Quit Friday, 30 Jan 2009 | 2:09 PM ET

    Pfizer is quitting the ad agency that tried to tell smokers it's their time to quit.